Breast and ovarian cancer newly linked to thousands of gene …
WEB1 day ago · Variants in this gene that stop the protein from working are known to increase the risk of breast and ovarian cancers and rarely, if there are two harmful gene changes present, may result in ...
Ovarian cancer is hard to detect, but new and better treatments …
WEBSep 6, 2022 · Advanced-stage ovarian cancer has a higher rate of recurrence, and Dr. Butler says early detection is important to improve survival.
A Game-Changer for Ovarian Cancer | Johns Hopkins Medicine
WEBJun 6, 2024 · Ovarian cancer is a notoriously difficult group of diseases to diagnose and treat. There is no effective screening method — most people have widely metastatic cancer when they start showing symptoms, and most patients die within five years. A new approach offers some hope in preventing this disease.
Antibody drug conjugates make strides in ovarian cancer with …
WEBFeb 12, 2024 · The UCLA Health women’s cancer research team in OBGYN played a pivotal role in a clinical trial that led to the FDA granting accelerated approval of the first antibody drug conjugate for the treatment of platinum-resistant ovarian cancer.
Ovarian cancer: New treatments and research
WEBMay 1, 2024 · If you've been diagnosed with ovarian cancer, he wants you to know there is hope. Here's why: New targeted therapies are improving survival. Surgery and chemotherapy are no longer the only options for ovarian cancer treatment. Targeted therapies use drugs to target and attack cancer cells.
FDA Approves New Treatment Option for Ovarian Cancer
WEBNov 17, 2022 · On November 14, the Food and Drug Administration (FDA) granted accelerated approval of Elahere (mirvetuximab soravtansine), a novel antibody-drug conjugate for people with previously treated ovarian, fallopian tube or primary peritoneal cancer who no longer respond to platinum chemotherapy.
Mirvetuximab Soravtansine-Gynx Approved for Ovarian Cancer
WEBApr 24, 2024 · Platinum-resistant ovarian cancer has proven difficult to treat, but with the Food and Drug Administration’s recent full approval of mirvetuximab soravtansine-gynx (Elahere), some people in this situation now have a new treatment option.
Preclinical Study Explores Approved Drug for Ovarian Cancer
WEBJul 29, 2024 · An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers.
Harnessing the immune system to fight ovarian cancer
WEBSep 19, 2023 · In ovarian cancer, Th17 cells are linked to reduced immune suppression and improved survival. By driving a Th17 immune response, the vaccine aims to redirect the immune system's efforts to fight cancer.
Trametinib to Treat Low-Grade Serous Ovarian Cancer - NCI
WEBMar 10, 2022 · New results from a large clinical trial provide the first strong evidence that a rare form of ovarian cancer, known as low-grade serous ovarian cancer, should be treated differently from other forms of the disease.